Blog

Although the concept of parity is straightforward in the abstract, it has proven to be extremely challenging for multiple state and federal regulators to develop and consistently apply a clear methodology for comparing all functions of modern managed care organizations. This is where accreditation can help.

CHQI is not the only organization to turn its focus towards the importance of measuring telemedicine outcomes – the industry as a whole echoes our sentiment.

Telehealth shows special promise to benefit patients, families and providers for treatment of substance use disorder (SUD), including opioid addiction.

Last month, The U.S. Centers for Medicare & Medicaid Services (CMS) finalized its plan to expand telehealth access and coverage in Medicare Advantage (MA) plans. There’s good news for MA plans, their members and providers: plans will be able to expand telehealth access and coverage beginning with plan year 2020 under a final rule published on April 5, 2019.

Just as policy is changing at the federal level to allow – and even encourage – greater use of telehealth and telemedicine programs, states, too, have been active. A number of states are in the process of updating telehealth laws and regulations, modernizing definitions to keep pace with available technology and services and setting rules for providers and plans.